Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2852 (LINC02852) is a human long non-coding RNA (lncRNA), classified as a long intergenic non-coding RNA (lincRNA).[3][7] It does not encode a protein and is not part of established therapeutic target classes such as receptors, enzymes, or transporters. LINC02852’s specific biological function is not described in the scientific literature or gene databases, though lincRNAs in general are recognized for their diverse regulatory roles in gene expression, chromatin modification, and potentially cancer pathogenesis, often by interacting with proteins that modify chromatin or by stabilizing molecular complexes.[10] There are no established drugs, therapeutic roles, or biomarker applications currently associated with LINC02852.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2852 (LINC02852).